FORCE platform overcomes barriers of oligonucleotide delivery to muscle and corrects myotonic dystrophy features in preclinical models
Timothy Weeden, Stefano Zanotti(University of Connecticut), Tama Evron, John K. Hall, Zhenzhi Tang(University of Rochester Medical Center), Ryan J. Russo, Ya-An Chang, Charles A. Thornton(University of Rochester Medical Center), Sean Spring(Abeona Therapeutics (United States)), Oxana Ibraghimov‐Beskrovnaya(Vyne Therapeutics (United States)), Bo Lan(Biogen (United States)), Cody A. Desjardins(Royal Holloway University of London), Nelson Hsia, John Najim, Mohammed Qatanani(Scholar Rock (United States)), Tyler Picariello, Reshmii Venkatesan, Romesh R. Subramanian(Pfizer (United States)), Brendan Quinn, L. Schlaefke, Nicholas C. Yoder(Tufts University), Matthew Tanner(University of Washington), Benjamin Vieira, Peiyi Shen, Monica Yao, Qifeng Qiu, Jin Cui, Katy N. Ovington(Vencore (United States)), Scott Hilderbrand, Aiyun Wen
Cited by 25
Related Papers
Mechanisms of obesity-associated insulin resistance: many choices on the menu
|Genes & Development|2007|781
Nuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver Regeneration
|Science|2006|635
Exome Capture Reveals ZNF423 and CEP164 Mutations, Linking Renal Ciliopathies to DNA Damage Response Signaling
|Cell|2012|392
Induction of bilirubin clearance by the constitutive androstane receptor (CAR)
|Proceedings of the National Academy of Sciences|2003|385